The syndrome of inappropriate mineralocorticoid receptor activation includes hypertension
Molecular and Cellular Endocrinology · 2026-10 · 112944
DOI: 10.1016/j.mce.2026.112944 ↗Kurz gefasst
Editorial in der Zeitschrift Molecular and Cellular Endocrinology, 2026-10. Verfasst von Elise P Gomez-Sanchez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, United States of America. Electronic address: egomez-sanchez@umc.edu. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, United States of America. Electronic address: egomez-sanchez@umc.edu.
- Department of Pharmacology & Toxicology, United States of America.
Zitieren
APA
Gomez-Sanchez, E. P., & Gomez-Sanchez, C. E. (2026). The syndrome of inappropriate mineralocorticoid receptor activation includes hypertension. Molecular and Cellular Endocrinology, 112944. https://doi.org/10.1016/j.mce.2026.112944
Vancouver
Gomez-Sanchez EP, Gomez-Sanchez CE. The syndrome of inappropriate mineralocorticoid receptor activation includes hypertension. Molecular and Cellular Endocrinology. 2026:112944. doi:10.1016/j.mce.2026.112944
BibTeX
@article{GomezSanchez2026,
author = {Gomez-Sanchez, Elise P and Gomez-Sanchez, Celso E},
title = {The syndrome of inappropriate mineralocorticoid receptor activation includes hypertension},
journal = {Molecular and Cellular Endocrinology},
year = {2026},
pages = {112944},
doi = {10.1016/j.mce.2026.112944}
}
EUVIMED